Our study supposed that LILRB4 may play a crucial role in modulating PD clinical characteristics by regulating nigrostriatal dopaminergic neuron function, AD‐related pathology, WM microstructural alterations, and astrocyte activation. Here, LILRB4 is linked to Parkinson disease.